🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧪 Power List 2025: Biopharmaceuticals Join us in celebrating the brilliant minds transforming the future of biopharmaceuticals — from therapeutic antibodies and protein engineering to platform technologies and biologics manufacturing. 🔗 ow.ly/x7sg50VJKZE #TMMPowerList25

Dive into the latest breakthroughs, challenges, and opportunities in Advanced Therapy Medicinal Products at the PDA ATMP Conference 2025 in Gothenburg, Sweden (June 26-27). Connect with industry leaders and experts! Register now: hubs.ly/Q036CP9J0 #AdvancedTherapies #ATMP

🚀 From Carl June to Kiran Mazumdar-Shaw — meet the pioneers shaping the future of pharma. Download Medicine-Making Pioneers free and get inspired by the industry's biggest voices. 📚 ow.ly/SUVv50VJx3i #TheMedicineMaker #PharmaInnovation #Pharma #DrugDevelopment

After his postdoc, Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. 💡 This interview explores how his career unfolded as he grew within the company he now leads. 📖 Read part 1: ow.ly/lKvW50VG5hL #STEMCareers #Colorcon

🧬 What’s shaping the future of gene therapy? We spoke to NewBiologix CEO Igor Fisch about trends, talent, and the tech driving the next wave of innovation. 🎧 Real insights from someone leading the charge. 📖 ow.ly/ocxV50VCet0 #GeneTherapy #Biotech

Daniel Chancellor, VP of Thought Leadership, wrote an article for The Medicine Maker on data proliferation for smarter decisions. That's where NorstellaLinQ, the biopharma industry's first fully integrated data asset, comes in. Read the article: ow.ly/C9Ym50Vjvf0

Catherine Bladen, VP, Regional Executive, and Principal Advisor of #VectorLaboratories shares her insights on the future of drug development in this insightful interview by Stephanie Vine in The Medicine Maker: bit.ly/3Hl4Bv4

🚀 The latest Issue of The Medicine Maker is here! We celebrate the leaders shaping the future of pharma with our annual Power List — featuring 30 influential figures across the industry 💥 Plus much more! 📲 Download the digital issue now: ow.ly/xZKZ50W3a7o

🧬 “You only have to be right once.” Dan Williams, CEO of SynaptixBio, opens up about the startup life in rare disease biotech. 📖 Read via The Medicine Maker: ow.ly/TMtp50VXAoT #RareDisease #Biotech #DrugDevlopment #Pharma

In The Medicine Maker, Tomasz Kostrzewski explores why U.S. FDA wants to shift away from animal testing and how a combinatorial approach to non-animal methods can allow companies to "more confidently progress promising drug candidates into the clinic." themedicinemaker.com/discovery-deve…

Connecting data dots improves drug development and clinical trials. Learn how NorstellaLinQ, a data asset, supports future innovations. Daniel Chancellor, VP at Norstella, shares his insights in The Medicine Maker (The Medicine Maker). ow.ly/Ie9y50VjvlF

GLP-1s are more than weight-loss drugs. Explore AI-driven design, novel delivery, and new indications in our expert-led eBook: Unpacking the GLP-1 Gold Rush 🔗 ow.ly/vRBM50WjM3w Sponsored by Charles River, DFE Pharma, Schott Pharma #GLP1 #Pharma

“I wanted to create something that mattered and that had an impact.” — Audrey Greenberg From Wall Street to cell therapy, Audrey's story blends bold pivots, biotech, and purpose. 📖 Read the feature: 🔗 ow.ly/B1Gu50WkcQo #Biotech #WomenInScience #CellTherapy

What if the “undruggable” could be drugged? Brian Paegel is developing covalent peptides that bind elusive transcription factors—offering new hope for tough-to-treat diseases. Full article → ow.ly/KKz050WifyK #PharmaInnovation #DrugDiscovery #CovalentPeptides

📘 Discover how Sartorius is scaling innovation in biomanufacturing. A new eBook explores its expanded Aubagne site, built for automation, digital integration, and sustainability. 🔗 Download here: ow.ly/4ViP50Wmhcg Kindly sponsored by Sartorius #Biomanufacturing

Vaccines. mRNA. ADCs. Cell lines. The future of drug development is here. 💊 Get insights from top experts in our new eBook, featuring Moncef Slaoui and more. 📘 Sponsored by Ecolab Life Sciences and Just – Evotec Biologics Download now: ow.ly/aioQ50WpTR1 #Biopharma

“We think we can separate metabolic benefit from GI side effects.” — Dr. Mathai Mammen, OrsoBio CEO A new oral drug aims to rival GLP-1s—without the nausea. 📖 Read the latest: 🔗 ow.ly/f0fF50Wkel6 #GLP1 #Obesity #Pharma

What does it take to make CAR-T work for solid tumors? John Maher, CSO of Leucid Bio, shares his journey from academia to biotech and lessons learned in translational science. 📖 Read the full interview: ow.ly/IO0S50Wmar3 #CART #Immunotherapy #Pharma

Proud to support #CGMesa25, North America’s top cell & gene therapy event. We’ll join the @‌Alliance for Regenerative Medicine and others on October 6-8 for 3 action-packed days exploring the latest challenges, developments, and innovations in #cellandgenetherapy.

Don't forget to download → Unpacking the GLP-1 Gold Rush Explore what’s next for GLP-1s: novel delivery, AI-designed peptides, and new indications. 🎯 Insights from Novo Nordisk, Charles River & more 📘 ow.ly/CSZs50WjMeY #GLP1 #Pharma #Biotech